Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBruising after a Mounjaro injection is common and, in most cases, completely harmless. Small marks appear because the KwikPen delivers tirzepatide into the fatty tissue just beneath the skin, where tiny capillaries can be nicked by the needle — no matter how carefully the injection is given. Most bruises from Mounjaro fade within a few days without any treatment. These are prescription-only injections; a GPhC-registered prescriber reviews whether Mounjaro is clinically suitable before any treatment begins at nume's consultation page.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Bruising with Mounjaro is not a sign that something has gone wrong with the medicine itself. The KwikPen deposits tirzepatide into subcutaneous fat (the soft layer between skin and muscle) using a thin, short needle. Even at the correct depth, that needle may pass through or graze a small blood vessel. Blood seeps into the surrounding tissue and oxidises, producing the familiar blue-purple discolouration.
A question our prescribers hear most weeks: "Is bruising a sign my injection went in wrong?" The honest answer is not usually. Capillaries sit throughout subcutaneous tissue in patterns you cannot see or predict. Even experienced self-injectors encounter the occasional bruise. What matters is depth and angle (the pen is designed for a 90-degree approach into a lifted skin fold) and that the site is not already bruised or tender from a previous injection.
The tirzepatide overview explains how the medicine works once it has been absorbed; the mechanism itself does not cause bruising. It is purely a physical consequence of the delivery route. Most marks are small, painless and gone within three to seven days.
Several things can increase how often or how visibly bruising happens, and most of them are manageable once you know to look for them.
Injecting into the same spot repeatedly is the most common culprit. Tissue that has been recently bruised is already fragile, so hitting the same area twice in quick succession multiplies the likelihood of another mark. Rotating systematically (abdomen one week, thigh the next, upper arm the week after) gives each site time to recover between doses. The bruising from Mounjaro page maps out a practical rotation approach.
Cold medicine is another factor worth knowing about. Injecting tirzepatide straight from the fridge can increase local discomfort and tissue irritation; letting the pen sit at room temperature for around 30 minutes before use is a commonly reported way to reduce both stinging and bruising. Check the Patient Information Leaflet or NHS tirzepatide guidance for the exact storage and pre-use instructions, as the permitted room-temperature window is defined there.
Certain medicines and supplements also thin the blood or affect platelet function, aspirin, ibuprofen, fish oil, vitamin E and anticoagulants being common examples. None of these are absolute barriers to using Mounjaro, but they are worth flagging to your prescriber so they can advise accordingly. And for some people, bruising easily is simply a baseline characteristic of their skin; it does not mean the treatment is not working or that anything is wrong.
Most people find that bruising with Mounjaro decreases over time as they refine their technique. A few habits make a real difference.
Clean dry skin at the injection site matters more than people expect. Rubbing an alcohol swab vigorously and injecting immediately afterwards, before the alcohol has fully dried, can increase irritation. Letting the site air-dry for a few seconds first is a small change that some patients say helps noticeably.
Avoid pressing the pen into the skin harder than needed to depress the button, gripping too firmly can distort the tissue and catch more vessels. Once the pen has been removed, apply gentle pressure with a clean piece of gauze or a cotton ball for ten to fifteen seconds rather than rubbing; rubbing spreads any small bleed under the skin and makes the bruise larger.
If you find bruising easily on Mounjaro is a consistent pattern rather than an occasional occurrence, it is worth mentioning at your next prescriber review. There may be a site preference that suits your tissue better, or a timing adjustment relative to other medicines you take.
For more on how the body typically responds in the first weeks of treatment, the Mounjaro timeline page covers what people commonly notice at each stage.
The vast majority of injection-site bruises from Mounjaro are minor and self-resolving. A small, slightly tender mark that fades over a few days needs nothing beyond normal care.
Seek prompt medical advice if a bruise spreads rapidly beyond the injection site, feels unusually hard or warm, is accompanied by significant pain that worsens rather than settles, or if you develop unexplained bruising elsewhere on the body that started around the same time as your treatment. These are not common, but they are worth acting on quickly.
Similarly, if the injection site becomes red, swollen and hot (rather than just discoloured) that may indicate a skin reaction or infection rather than a straightforward bruise. This is covered in more detail on the Mounjaro bruise page, which also addresses what a normal bruise looks like versus what warrants a call to your GP. Any suspected side effects can also be reported directly through the MHRA Yellow Card scheme.
If you are thinking about starting Mounjaro and want to understand the full side-effect profile before committing, the Mounjaro overview is a good starting point. And if cost is part of your thinking, the Mounjaro cost context page explains what private treatment typically involves and what legitimate pricing looks like in the UK.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.